Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice

Gut Microbes

Volumn 9, Issue 2, 2018, Pages 115-130

  Allen, J M ^a   Mailing, L J ^a   Cohrs, J ^a   Salmonson, C ^b   Fryer, J D ^c   Nehra, V ^b   Hale, V L ^d   Kashyap, P ^b   White, B A ^a   Woods, J A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

colitis; colonization inflammation; exercise; germ free; gut; microbiome; microbiota; transplant; voluntary wheel running

Indexed keywords

COENZYME A TRANSFERASE; SHORT CHAIN FATTY ACID; CYTOKINE; DEXTRAN SULFATE; VOLATILE FATTY ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; COHORT ANALYSIS; CONTROLLED STUDY; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; DNA ISOLATION; EXERCISE; FATTY ACID ANALYSIS; FECAL MICROBIOTA TRANSPLANTATION; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENE SEQUENCE; GNOTOBIOTICS; HISTOLOGY; INTESTINE FLORA; LACHNOSPIRACEAE; MALE; MICROBIAL COLONIZATION; MOUSE; NONHUMAN; PARABACTEROIDES; PREVOTELLA; REAL TIME POLYMERASE CHAIN REACTION; RECTUM HEMORRHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUMINOCOCCUS; ANATOMY AND HISTOLOGY; ANIMAL; C57BL MOUSE; CECUM; CHEMICALLY INDUCED; COLITIS; COLON; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SEX FACTOR;

ANIMALS; BODY WEIGHT; CECUM; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FATTY ACIDS, VOLATILE; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; GERM-FREE LIFE; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; PHYSICAL CONDITIONING, ANIMAL; SEX FACTORS;

EID: 85029896595     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2017.1372077     Document Type: Article

References (56)

1. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, et al. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev. 2011;17:6-63. PMID:21446352
2. Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ, Oliver SJ, Bermon S, Kajeniene A. Position statement. Part two: Maintaining immune health. Exerc Immunol Rev. 2011;17:64-103. PMID:21446353
3. Allen JM, Berg Miller ME, Pence BD, Whitlock K, Nehra V, Gaskins HR, White BA, Fryer JD, Woods JA. Voluntary and forced exercise differentially alters the gut microbiome in C57BL/6J mice. J Appl Physiol (1985). 2015;118:1059-66. doi:10.1152/japplphysiol.01077.2014. PMID:25678701
4. Mika A, Van Treuren W, Gonzalez A, Herrera JJ, Knight R, Fleshner M. Exercise is More Effective at Altering Gut Microbial Composition and Producing Stable Changes in Lean Mass in Juvenile versus Adult Male F344 Rats. PLoS One. 2015;10:e0125889. doi:10.1371/journal.pone.0125889. PMID:26016739
5. Choi JJ, Eum SY, Rampersaud E, Daunert S, Abreu MT, Toborek M. Exercise attenuates PCB-induced changes in the mouse gut microbiome. Environ Health Perspect. 2013;121:725-30. doi:10.1289/ehp.1306534. PMID:23632211
6. Matsumoto M, Inoue R, Tsukahara T, Ushida K, Chiji H, Matsubara N, Hara H. Voluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecum. Biosci Biotechnol Biochem. 2008;72:572-6. doi:10.1271/bbb.70474. PMID:18256465
7. Queipo-Ortuno MI, Seoane LM, Murri M, Pardo M, Gomez-Zumaquero JM, Cardona F, Casanueva F, Tinahones FJ. Gut Microbiota Composition in Male Rat Models under Different Nutritional Status and Physical Activity and Its Association with Serum Leptin and Ghrelin Levels. PloS one. 2013;8:e65465. doi:10.1371/journal.pone.0065465. PMID:23724144
8. Kang SS, Jeraldo PR, Kurti A, Miller ME, Cook MD, Whitlock K, Goldenfeld N, Woods JA, White BA, Chia N, et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener. 2014;9:36. doi:10.1186/1750-1326-9-36. PMID:25217888
9. Evans CC, Lepard KJ, Kwak JW, Stancukas MC, Laskowski S, Dougherty J, Moulton L, Glawe A, Wang Y, Leone V, et al. Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity. PLoS One. 2014;9:e92193. doi:10.1371/journal.pone.0092193. PMID:24670791
10. Lambert JE, Myslicki JP, Bomhof MR, Belke DD, Shearer J, Reimer RA. Exercise training modifies gut microbiota in normal and diabetic mice. Appl Physiol Nutr Metab. 2015;40:749-52. doi:10.1139/apnm-2014-0452. PMID:25962839
11. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213-23. doi:10.1016/j.chom.2008.02.015. PMID:18407065
12. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621-6. doi:10.1038/nature11400. PMID:22914093
13. Rokhsefat S, Lin A, Comelli EM. Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications. Dig Dis Sci. 2016. doi:10.1007/s10620-016-4032-6. PMID:26792279
14. Earle KA, Billings G, Sigal M, Lichtman JS, Hansson GC, Elias JE, Amieva MR, Huang KC, Sonnenburg JL. Quantitative Imaging of Gut Microbiota Spatial Organization. Cell host & microbe. 2015;18:478-88. doi:10.1016/j.chom.2015.09.002.
15. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003;52:1442-7. doi:10.1136/gut.52.10.1442. PMID:12970137
16. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31. doi:10.1038/nature05414. PMID:17183312
17. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364-71. doi:10.2337/db11-1019. PMID:22190648
18. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451-5. doi:10.1038/nature12726. PMID:24226773
19. Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152(2):313-21.
20. Kanauchi O, Mitsuyama K, Andoh A. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15:2074-86. doi:10.2174/138161209788489195. PMID:19519445
21. Cario E., Microbiota and innate immunity in intestinal inflammation and neoplasia. Curr Opin Gastroenterol. 2013;29:85-91. doi:10.1097/MOG.0b013e32835a670e. PMID:23207600
22. Moehle C, Ackermann N, Langmann T, Aslanidis C, Kel A, Kel-Margoulis O, Schmitz-Madry A, Zahn A, Stremmel W, Schmitz G. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med (Berl). 2006;84:1055-66. doi:10.1007/s00109-006-0100-2. PMID:17058067
23. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2009;15:100-13. doi:10.1002/ibd.20539. PMID:18623167
24. Cleynen I, Vermeire S. Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol. 2012; 9: 496-503. doi:10.1038/nrgastro.2012.125. PMID:22751454
25. George LA, Gadani A, Cross RK, Jambaulikar G, Ghazi LJ. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease. Dig Dis Sci. 2015;60:3424-30. doi:10.1007/s10620-015-3763-0. PMID:26115749
26. Lemann M. Treatment of chronic inflammatory bowel diseases. Bull Acad Natl Med. 2007;191:1125-41; discussion 41. PMID:18402168
27. Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wójcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacological reports: PR. 2016;68:827-36. doi:10.1016/j.pharep.2016.04.009. PMID:27255494
28. Trojian TH, Mody K, Chain P. Exercise and colon cancer: primary and secondary prevention. Curr Sports Med Rep. 2007;6:120-4. PMID:17376341
29. Cook MD, Martin SA, Williams C, Whitlock K, Wallig MA, Pence BD, Woods JA. Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav Immun. 2013;33:46-56. doi:10.1016/j.bbi.2013.05.005. PMID:23707215
30. Bilski J, Mazur-Bialy AI, Brzozowski B, Magierowski M, Jasnos K, Krzysiek-Maczka G, Urbanczyk K, Ptak-Belowska A, Zwolinska-Wcislo M, Mach T, et al. Moderate exercise training attenuates the severity of experimental rodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles. Mediators of inflammation. 2015;2015:605071v10.1155/2015/605071. PMID:25684862
31. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635-42. doi:10.1136/gut.2010.215665. PMID:20926643
32. Louis P, Flint HJ. Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol. 2007;73:2009-12. doi:10.1128/AEM.02561-06. PMID:17259367
33. Brinkman BM, Becker A, Ayiseh RB, Hildebrand F, Raes J, Huys G, Vandenabeele P. Gut microbiota affects sensitivity to acute DSS-induced colitis independently of host genotype. Inflamm Bowel Dis. 2013;19:2560-7. doi:10.1097/MIB.0b013e3182a8759a. PMID:24105395
34. Liang X, Li H, Tian G, Li S. Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer. Sci Rep. 2014;4:4985. doi:10.1038/srep04985. PMID:24828543
35. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066-71. doi:10.1073/pnas.1219451110. PMID:23671105
36. Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio. 2014;5:e00889. doi:10.1128/mBio.00889-14. PMID:24757212
37. Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, Subramanian S, Manary MJ, Trehan I, Jorgensen JM, et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science. 2016;351:830-7. doi:10.1126/science.aad3311. PMID:26912898.
38. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539-44. doi:10.1126/science.aad9378. PMID:27126036
39. Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2009;60:97-110. doi:10.1146/annurev.med.60.051407.123757. PMID:18976050
40. Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, Merad M. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343:1249288. doi:10.1126/science.1249288. PMID:24625929
41. Cherayil BJ. Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation. Inflamm Bowel Dis. 2009;15:1391-6. doi:10.1002/ibd.20910. PMID:19322906
42. Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, Obrist P, Fuchs D, Brandacher G, Winkler C, Geboes K, et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol. 2004;113:47-55. doi:10.1016/j.clim.2004.05.004. PMID:15380529
43. Clarke G, McKernan DP, Gaszner G, Quigley EM, Cryan JF, Dinan TG. A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome. Front Pharmacol. 2012;3:90. doi:10.3389/fphar.2012.00090. PMID:22661947
44. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275-83. doi:10.1136/gutjnl-2013-304833. PMID:24021287
45. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-42. doi:10.1038/39614. PMID:9338786
46. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996;183:2669-74. doi:10.1084/jem.183.6.2669. PMID:8676088
47. Becker C, Fantini MC, Neurath MF. TGF-beta as a T cell regulator in colitis and colon cancer. Cytokine Growth Factor Rev. 2006;17:97-106. doi:10.1016/j.cytogfr.2005.09.004. PMID:16298544
48. Chen J, Xie L, Toyama S, Hünig T, Takahara S, Li XK, Zhong L. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis. Int Immunopharmacol. 2011;11:610-7. doi:10.1016/j.intimp.2010.11.034. PMID:21163250
49. Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad JM, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22:598-605. doi:10.1038/nm.4102. PMID:27158904
50. Martin JC, Beriou G, Heslan M, Bossard C, Jarry A, Abidi A, Hulin P, Ménoret S, Thinard R, Anegon I, et al. IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunol. 2016;9:539-49. doi:10.1038/mi.2015.83. PMID:26329427
51. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534-44. PMID:18172556
52. Bergstrom KS, Morampudi V, Chan JM, Bhinder G, Lau J, Yang H, Ma C, Huang T, Ryz N, Sham HP, et al. Goblet Cell Derived RELM-beta Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation. PLoS Pathog. 2015;11:e1005108. doi:10.1371/journal.ppat.1005108. PMID:26285214
53. Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, Sjövall H, Hansson GC. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PloS One. 2010;5:e12238. doi:10.1371/journal.pone.0012238. PMID:20805871
54. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4516-22. doi:10.1073/pnas.1000080107. PMID:20534432
55. Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, Kühl AA. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7:4557-76. PMID:25197329
56. Panasevich MR, Allen JM, Wallig MA, Woods JA, Dilger RN. Moderately Fermentable Potato Fiber Attenuates Signs and Inflammation Associated with Experimental Colitis in Mice. J Nutr. 2015;145:2781-8. doi:10.3945/jn.115.218578. PMID:26491118